1.
Sung, Y ; Dézsi, K ; Patócs, A ; Barzó, P ; Dumele, A ; Féhér, M ; Farkas, Á ; Deák, P ; Nyilas, N ; Szabó, V et al.
VON HIPPEL–LINDAU-KÓRKÉP MULTIDISZCIPLINÁRIS KEZELÉSE ÉS AZ ÉLETMINŐSÉG ÖSSZEFÜGGÉSE
MAGYAR BELORVOSI ARCHIVUM 77 : 5-6 pp. 356-357. , 2 p. (2024)
Other URL
Publication:35711510 Validated Core Journal Article (Abstract ) Scientific
Abstract (Journal Article) | Scientific[35711510] [Validated]
2.
Verma, S. ✉ ; Wanner, C. ; Zwiener, I. ; Ofstad, A.P. ; George, J.T. ; Fitchett, D. ; Zinman, B. ; EMPA-REG, OUTCOME Investigators (Collaborative Organization) ; Dudas, M (Collaborator) ; Nagy, K (Collaborator) et al.
Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 73 : 21 pp. 2780-2782. , 3 p. (2019)
DOI WoS Scopus PubMed
Publication:31300303 Validated Core Citing Journal Article (Comment, Correction ) Scientific
Citing papers: 40 | Independent citation: 31 | Self citation: 9 | Unknown citation: 0 | Number of citations in WoS: 37 | Number of citations in Scopus: 39 | WoS/Scopus assigned: 40 | Number of citations with DOI: 40
Comment, Correction (Journal Article) | Scientific[31300303] [Validated]
All citations+mentions: 40, External citations: 31, Self citations: 9, Unhandled citations: 0
3.
Wanner, Christoph ; Heerspink, Hiddo J. L. ; Zinman, Bernard ; Inzucchi, Silvio E. ; Koitka-Weber, Audrey ; Mattheus, Michaela ; Hantel, Stefan ; Woerle, Hans-Juergen ; Broedl, Uli C. ; von Eynatten, Maximilian et al.
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 29 : 11 pp. 2755-2769. , 15 p. (2018)
DOI WoS Scopus PubMed
Publication:30703833 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 178 | Independent citation: 153 | Self citation: 25 | Unknown citation: 0 | Number of citations in WoS: 167 | Number of citations in Scopus: 165 | WoS/Scopus assigned: 178 | Number of citations with DOI: 171 (Not published: 2)
Study Group (Journal Article) | Scientific[30703833] [Validated]
All citations+mentions: 178, External citations: 153, Self citations: 25, Unhandled citations: 0
4.
EMPA-REG OUTCOME Investigators (Collaborative Organization) ; Wanner, Christoph ; Lachin, John M ; Inzucchi, Silvio E ; Fitchett, David ; Mattheus, Michaela ; George, Jyothis ; Woerle, Hans J ; Broedl, Uli C ; von Eynatten, Maximilian et al.
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
CIRCULATION 137 : 2 pp. 119-129. , 11 p. (2018)
DOI WoS Scopus PubMed
Publication:31209130 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 425 | Independent citation: 387 | Self citation: 38 | Unknown citation: 0 | Number of citations in WoS: 390 | Number of citations in Scopus: 394 | WoS/Scopus assigned: 425 | Number of citations with DOI: 404 (Not published: 3)
Study Group (Journal Article) | Scientific[31209130] [Validated]
All citations+mentions: 425, External citations: 387, Self citations: 38, Unhandled citations: 0
5.
Fitchett, D ; Butler, J ; van de Borne, P ; Zinman, B ; Lachin, JM ; Wanner, C ; Woerle, HJ ; Hantel, S ; George, JT ; Johansen, OE et al.
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrumof heart failure risk in the EMPA-REG OUTCOME (R) trial
EUROPEAN HEART JOURNAL 39 : 5 pp. 363-370. , 8 p. (2018)
DOI WoS Scopus PubMed
Publication:31209141 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 229 | Independent citation: 208 | Self citation: 21 | Unknown citation: 0 | Number of citations in WoS: 210 | Number of citations in Scopus: 214 | WoS/Scopus assigned: 229 | Number of citations with DOI: 216
Study Group (Journal Article) | Scientific[31209141] [Validated]
All citations+mentions: 229, External citations: 208, Self citations: 21, Unhandled citations: 0
6.
Zinman, Bernard ; Inzucchi, Silvio E ; Wanner, Christoph ; Hehnke, Uwe ; George, Jyothis T ; Johansen, Odd Erik ; Fitchett, David ; EMPA-REG OUTCOME® investigators (Collaborative Organization) ; Dudas, M (Collaborator) ; Nagy, K (Collaborator) et al.
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®
DIABETOLOGIA 61 : 7 pp. 1522-1527. , 6 p. (2018)
DOI WoS Scopus PubMed
Publication:31307246 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 64 | Independent citation: 54 | Self citation: 10 | Unknown citation: 0 | Number of citations in WoS: 59 | Number of citations in Scopus: 58 | WoS/Scopus assigned: 64 | Number of citations with DOI: 61 (Not published: 1)
Study Group (Journal Article) | Scientific[31307246] [Validated]
All citations+mentions: 64, External citations: 54, Self citations: 10, Unhandled citations: 0
7.
Zinman, Bernard ; Inzucchi, Silvio E ; Lachin, John M ; Wanner, Christoph ; Fitchett, David ; Kohler, Sven ; Mattheus, Michaela ; Biomath, Dipl ; Woerle, Hans J ; Broedl, Uli C et al.
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
STROKE 48 : 5 pp. 1218-1225. , 31 p. (2017)
DOI WoS Scopus PubMed
Publication:26756488 Admin approved Core Citing Journal Article (Study Group ) Scientific
Citing papers: 126 | Independent citation: 119 | Self citation: 7 | Unknown citation: 0 | Number of citations in WoS: 118 | Number of citations in Scopus: 117 | WoS/Scopus assigned: 126 | Number of citations with DOI: 117
Study Group (Journal Article) | Scientific[26756488] [Admin approved]
All citations+mentions: 126, External citations: 119, Self citations: 7, Unhandled citations: 0
8.
Kaku, Kohei ; Lee, Jisoo ; Mattheus, Michaela ; Kaspers, Stefan ; George, Jyothis ; Woerle, Hans-Juergen ; on behalf of the EMPA-REG OUTCOME® Investigators (Collaborative Organization) ; Dudas, M (Collaborator) ; Nagy, K (Collaborator) ; Salamon, C (Collaborator) et al.
Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease ― Results From EMPA-REG OUTCOME® ―
CIRCULATION JOURNAL: OFFICIAL JOURNAL OF THE JAPANESE CIRCULATION SOCIETY 81 : 2 pp. 227-234. , 8 p. (2017)
DOI WoS Scopus
Publication:31308918 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 130 | Independent citation: 114 | Self citation: 16 | Unknown citation: 0 | Number of citations in WoS: 121 | Number of citations in Scopus: 114 | WoS/Scopus assigned: 130 | Number of citations with DOI: 128
Study Group (Journal Article) | Scientific[31308918] [Validated]
All citations+mentions: 130, External citations: 114, Self citations: 16, Unhandled citations: 0
9.
Wanner, Christoph ✉ ; Inzucchi, Silvio E. ; Lachin, John M. ; Fitchett, David ; von Eynatten, Maximilian ; Mattheus, Michaela ; Johansen, Odd Erik ; Woerle, Hans J. ; Broedl, Uli C. ; Zinman, Bernard et al.
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
NEW ENGLAND JOURNAL OF MEDICINE 375 : 4 pp. 323-334. , 12 p. (2016)
DOI WoS Scopus PubMed
Publication:31230059 Validated Core Citing Journal Article (Study Group ) Scientific
Citing papers: 2,997 | Independent citation: 2,598 | Self citation: 399 | Unknown citation: 0 | Number of citations in WoS: 2,759 | Number of citations in Scopus: 2,825 | WoS/Scopus assigned: 2,997 | Number of citations with DOI: 2,877
Study Group (Journal Article) | Scientific[31230059] [Validated]
All citations+mentions: 2997, External citations: 2598, Self citations: 399, Unhandled citations: 0
10.
Kun, A ; Tabák, G Á ; Sudár, Z ; Tornóczky, J ; Vargha, P ; Kerényi, Z ; Tamás, G
Teljes körű GDM-szűrés értékelése a WHO és az IADPSG kritériumrendszere alapján
DIABETOLOGIA HUNGARICA 22 pp. 201-206. , 6 p. (2014)
Matarka
Publication:3078519 Validated Core Journal Article (Article ) Scientific
Article (Journal Article) | Scientific[3078519] [Validated]
2026-08-19 14:20